99
Views
1
CrossRef citations to date
0
Altmetric
Patent Evaluation

The use of iron chelators in biocidal compositions: evaluation of patent, WO2014059417A1

, , &

Bibliography

  • Fairbanks VF, Beutler E. Iron metabolism. Williams Hematology 1995;6:295-304
  • Dunn LL, Rahmanto YS, Richardson DR. Iron uptake and metabolism in the new millennium. Trends Cell Biol 2007;17:93-100
  • Marx J. Iron and infection: competition between host and microbes for a precious element. Best Pract Res Clin Haematol 2002;15:411-26
  • Ballouche M, Cornelis P, Baysse C. Iron metabolism: a promising target for antibacterial strategies. Recent Pat Antiinfect Drug Discov 2009;4:190-205
  • Bergeron R, Elliott G, Kline S, et al. Bacteriostatic and fungostatic action of catecholamide iron chelators. Antimicrob Agents Chemother 1983;24:725-30
  • Bertrand S, Helesbeux J-J, Larcher G, et al. Hydroxamate, a Key Pharmacophore Exhibiting a Wide Range of Biological Activities. Mini Rev Med Chem 2013;13:1311-26
  • Jones RL, Grady RW. Siderophores as antimicrobial agents. Eur J Clin Microbiol Infect Dis 1983;2:411-13
  • Van Asbeck B, Marcelis J, Marx J, et al. Inhibition of bacterial multiplication by the iron chelator deferoxamine: potentiating effect of ascorbic acid. Eur J Clin Microbiol 1983;2:426-31
  • Ellis S, Kalinowski DS, Leotta L, et al. Potent Antimycobacterial Activity of the Pyridoxal Isonicotinoyl Hydrazone Analog 2-Pyridylcarboxaldehyde Isonicotinoyl Hydrazone: a Lipophilic Transport Vehicle for Isonicotinic Acid Hydrazide. Mol Pharmacol 2014;85:269-78
  • Debebe Z, Ammosova T, Breuer D, et al. Iron chelators of the di-2-pyridylketone thiosemicarbazone and 2-benzoylpyridine thiosemicarbazone series inhibit HIV-1 transcription: identification of novel cellular targets--iron, cyclin-dependent kinase (CDK) 2, and CDK9. Mol Pharmacol 2011;79:185-96
  • Warner RR, Schwartz JR, Boissy Y, et al. Dandruff has an altered stratum corneum ultrastructure that is improved with zinc pyrithione shampoo. J Am Acad Dermatol 2001;45:897-903
  • Akhavan A, Bershad S. Topical acne drugs: review of clinical properties, systemic exposure, and safety. Am J Clin Dermatol 2003;4:473-92
  • Alvarez OM, Mertz PM, Eaglstein WH. Benzoyl peroxide and epidermal wound healing. Arch Dermatol 1983;119:222-5
  • Williams HC, Dellavalle RP, Garner S. Acne vulgaris. Lancet 2012;379:361-72
  • Board of Regents. The University of Texas System. M-EDTA pharmaceutical preparations and uses thereof. US5362754A;1994
  • Wen J, Zhao K, Gu T, et al. Chelators enhanced biocide inhibition of planktonic sulfate-reducing bacterial growth. World J Microbiol Biotechnol 2010;26:1053-7
  • Wen J, Zhao K, Gu T, et al. A green biocide enhancer for the treatment of sulfate-reducing bacteria (SRB) biofilms on carbon steel surfaces using glutaraldehyde. Int Biodeterior Biodegrad 2009;63:1102-6

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.